Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,464
Recruiting: 821
Ph III recruiting: 96
Growth YoY: +6%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

clinicaltrialsPublishedShowing 751–800 of 1,389 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03563781	SEntine Lymph Node in earLY Ovarian Cancer (SELLY)(SELLY)	completed	N/A	176	Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER	1	Jun 22, 2023	clinicaltrials
NCT04952961	Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study	completed	N/A	25	University of ManchesterOTHER	1	Jun 22, 2023